Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 57 results:
[ Συντάκτης] Τίτλος Τύπος Έτος Φίλτρα: Συντάκτης is Anagnostis, Panagiotis [Clear All Filters]
Vitamin D Supplementation and Cardiovascular Disease Risk..
JAMA Cardiol. 2(11), 1281-1282.
(2017). Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies..
Endocrine. 74(2), 245-253.
(2021). Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience..
Pituitary. 15(1), 25-9.
(2012). 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?.
Metabolism. 62(1), 21-33.
(2013). Estrogen and bones after menopause: a reappraisal of data and future perspectives..
Hormones (Athens).
(2020). Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study..
Open Cardiovasc Med J. 8, 55-60.
(2014). Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis..
Eur J Endocrinol. 180(1), 41-50.
(2019). Calcium and Vitamin D Supplements and Fractures in Community-Dwelling Adults..
JAMA. 319(19), 2041.
(2018). Adrenal incidentaloma: a diagnostic challenge..
Hormones (Athens). 8(3), 163-84.
(2009).
(2020). Is there any association between leptin levels and bone mineral density in haemophiliac men?.
Arch Med Sci. 9(3), 459-65.
(2013). Management of dyslipidaemias in the elderly population-A narrative review..
Maturitas. 124, 93-99.
(2019). The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis..
Maturitas. 99, 27-36.
(2017). Bone Health in Patients with Dyslipidemias: An Underestimated Aspect..
Int J Mol Sci. 23(3),
(2022). Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study..
Indian J Endocrinol Metab. 16(1), 146-7.
(2012). Reduced bone mineral density in patients with haemophilia A and B in Northern Greece..
Thromb Haemost. 107(3), 545-51.
(2012). Vascular surgical procedures in patients with familial hypercholesterolaemia: is it too late?.
Curr Med Res Opin. 36(8), 1255.
(2020). The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes..
Lancet Diabetes Endocrinol. 2(5), 362-3.
(2014). New therapeutic targets for osteoporosis..
Maturitas. 120, 1-6.
(2019). Management of Acute Hip Fracture..
N Engl J Med. 378(10), 971-2.
(2018). Endocrine Disease as a Cause of Cardiovascular Disease: Current Perspectives..
Curr Pharm Des. 26(43), 5547-5550.
(2020). Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis..
J Clin Endocrinol Metab. 94(8), 2692-701.
(2009). Cushing's Syndrome and Cardiovascular Risk..
Curr Vasc Pharmacol. 18(1), 25-26.
(2020). The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture..
Thromb Haemost. 110(2), 257-63.
(2013). "Holidays" for osteoporosis drugs: A case-based approach..
Case Rep Womens Health. 23, e00127.
(2019).